Yara Hahr Marques Hökerberg

Yara Hahr Marques Hökerberg

Auto-generated profile, based on publicly available information

Yara Hahr Marques Hökerberg

Fundação Oswaldo Cruz, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Journal of Pediatric Nursing
Verified
Journal Article
Closed access
AAAndrea Moreira Arrué
Andrea Moreira Arrué
YHYara Hahr Marques Hökerberg
Yara Hahr Marques Hökerberg
LJLeonardo Bigolin Jantsch
Leonardo Bigolin Jantsch
SGSilvana Granado Nogueira da Gama
Silvana Granado Nogueira da Gama
RORaquel de Vasconcellos Carvalhaes de Oliveira
Raquel de Vasconcellos Carvalhaes de Oliveira
ENEliane Tatsch Neves
Eliane Tatsch Neves

1 January 2020 in Cadernos de Saude Publica
Verified
Journal Article
Open access
PDF file
VMVerónica Elizabeth Mata
Verónica Elizabeth Mata
CACARLOS AUGUSTO FERREIRA DE ANDRADE
CARLOS AUGUSTO FERREIRA DE ANDRADE
SPSonia Regina Lambert Passos CAPES 88881 130793 Passos
Sonia Regina Lambert Passos CAPES 88881 130793 Passos
YHYara Hahr Marques Hökerberg
Yara Hahr Marques Hökerberg
LFLevy Vilas Boas Fukuoka
Levy Vilas Boas Fukuoka
SSSuzana Alves da Silva
Suzana Alves da Silva
Dengue is an important arthropod-borne viral disease in terms of morbidity, mortality, economic impact and challenges in vector control. Benchmarks are expensive, time consuming and require trained personnel. Preventing dengue complications with rapid diagnosis has been based on the testing of easy-to-perform optimized immunochromatographic methods (ICT). This is a systematic meta-analysis review of the diagnostic accuracy of IgA, NS1, IgM and/or IgG ICT studies in suspected cases of acute or convalescent dengue, using a combination of RT-PCR, ELISA NS1, IgM IgG or viral isolation as a reference standard. This protocol was registered in PROSPERO (CRD42014009885). Two pairs of reviewers searched the PubMed, BIREME, Science Direct, Scopus, Web of Science, Ovid MEDLINE JBrigs, SCIRUS and EMBASE databases, selected, extracted, and quality-assessed by QUADAS 2. Of 3,783 studies, we selected 57, of which 40 in meta-analyses according to the analyte tested, with high heterogeneity (I2 > 90%), as expected for diagnostic tests. We detected higher pooled sensitivity in acute phase IgA (92.8%) with excellent (90%) specificity. ICT meta-analysis with NS1/IgM/IgG showed 91% sensitivity and 96% specificity. Poorer screening performance was for IgM/IgG ICT (sensitivity = 56%). Thus, the studies with NS1/IgM/IgG ICT showed the best combined performance in the acute phase of the disease.

23 October 2017 in AIDS Care
Verified
Journal Article
Closed access
RORaquel de Vasconcellos Carvalhaes de Oliveira
Raquel de Vasconcellos Carvalhaes de Oliveira
SSSilvia Emiko Shimakura
Silvia Emiko Shimakura
DCDayse Pereira Campos
Dayse Pereira Campos
YHYara Hahr Marques Hökerberg
Yara Hahr Marques Hökerberg
FVFlaviana Pavan Victoriano
Flaviana Pavan Victoriano
MCMarilia Sá Carvalho
Marilia Sá Carvalho
The use of highly active antiretroviral therapy has resulted in changes of comorbidity profile in people living with HIV (PLHIV), increasing non-AIDS-related events. The occurrence of cardiovascular events is greater in PLHIV, but the mechanism responsible for it is still controversial. This article aimed to investigate factors associated with the progression to cardiovascular events in PLHIV using HAART. A 15-years cohort study with 1135 PLHIV was conducted in Rio de Janeiro-Brazil. Clinical progression was stratified in five states: No comorbidities (s1), arterial hypertension (s2), lipid abnormalities (s3), hypertension and lipid abnormalities (s4) and major cardiovascular events (stroke, coronary artery disease, thrombosis or death) (s5). Semi-Markov models evaluated the effects of cardiovascular traditional factors, treatment and clinical covariates on transitions between these states. Hazard Ratios (HR) and 95% confidence intervals (CI) were provided. In addition to traditional factors (age, sex, educational level and skin color), the development of one comorbidity (lipid abnormalities or hypertension) increased in patients with low nadir CD4 (<50 cells/mm3), (HR = 1.59, CI 1.11–2.28 and 1.36, CI 1.11–1.66, respectively). The risk to experience a second comorbidity (s3→s4) increased 75% with low nadir CD4. Age was the only factor that increased the risk of major cardiovascular events once having lipid abnormalities with or without hypertension (s3,s4→s5). The prolonged use of certain antiretroviral drugs (abacavir, didanosine, ritonavir, lopinavir, amprenavir and fosamprenavir) increased the risk of direct transition (s1→s5) to major cardiovascular events (HR = 5.29, CI 1.16–24.05). This analysis suggests that prolonged use of certain antiretroviral drugs led directly to major cardiovascular events, while low nadir CD4 only affected the occurrence of lipid abnormalities and hypertension. Management strategies, including rational use of complex exams (such as, computed-tomography angiography), statins and antihypertensives, should be developed based on the distinct roles of antiretroviral use and of HIV infection itself on the progression to cardiovascular events.

29 August 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
VMVerónica Elizabeth Mata
Verónica Elizabeth Mata
SPSonia Regina Lambert Passos CAPES 88881 130793 Passos
Sonia Regina Lambert Passos CAPES 88881 130793 Passos
YHYara Hahr Marques Hökerberg
Yara Hahr Marques Hökerberg
GBGuilherme Miguéis Berardinelli
Guilherme Miguéis Berardinelli
MSMaria Angelica Borges dos Santos
Maria Angelica Borges dos Santos
RORaquel de Vasconcellos Carvalhaes de Oliveira
Raquel de Vasconcellos Carvalhaes de Oliveira
Rapid immunochromatographic tests (ICT) for dengue non-structural protein 1 (NS1) have shown good performance for diagnosing acute-phase dengue in serum in laboratory settings, but rarely have been assessed in whole blood and at point of care (POC). This study compare the accuracy and inter- and intra-observer reliability of the NS1 Bioeasy™ ICT in whole blood at POC versus serum in the laboratory, during a DENV-1 epidemic. Cross-sectional study involving 144 adults spontaneously demanding care in an emergency department within 4 days of onset of acute febrile illness. Accuracy of NS1 Bioeasy™ ICT was compared in whole blood and serum, both at 15 and 30 min, blinded to the reference RT-PCR or NS1 ELISA. Non-dengue patients were also tested for Zika virus with RT-PCR. Reliability of whole blood and serum readings by the same or different observers was measured by simple kappa (95% CI). At 15 min, sensitivity (Sn) of NS1 Bioeasy™ ICT in whole blood/POC was 76.7% (95% CI: 68.0–84.1) and specificity (Sp) was 87.0% (95% CI: 66.4–97.2). Sn in serum/laboratory was 82% (95% CI: 74.1–88.6) and Sp 100% (95% CI: 85.8–100). Positive likelihood ratio was 5.9 (95% CI: 2.0–17.0) for whole blood/POC and 19.8 (95% CI: 2.9–135.1) for serum/laboratory. Reliability of matched readings of whole blood/POC and serum/laboratory by the same observer (k = 0.83, 95% CI: 0.74–0.93) or different observers (k = 0.81, 95% CI: 0.72–0.92) was almost perfect, with higher discordant levels in the absence of dengue. Results did not differ statistically at 5%. NS1 Bioeasy™ ICT in DENV-1 epidemics is a potentially confirmatory test. Invalid results at 15 min should be reread at 30 min. To optimize impact of implementing ICT in the management of false-negatives it should be incorporated into an algorithm according to setting and available specimen. UTN U1111-1145-9451 .

1 January 2022 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
YHYara Hahr Marques Hökerberg
Yara Hahr Marques Hökerberg
FKFernanda Kohn
Fernanda Kohn
TSTaís Suane de Souza
Taís Suane de Souza
SPSonia Regina Lambert Passos CAPES 88881 130793 Passos
Sonia Regina Lambert Passos CAPES 88881 130793 Passos
Population aging and mobility have increased the exposure of elderly individuals to dengue. This study evaluated the clinical features of dengue in the elderly during the epidemic (2008 and 2012) and interepidemic (2009 and 2010) periods. This cross-sectional study was based on dengue surveillance data from Rio de Janeiro, Brazil: 2008 (n=31,210), 2009‒2010 (n=2,884), and 2012 (n=30,773). The analysis was stratified by age group (<60 and ≥60 years). Case-fatality rates were higher in the elderly. In 2008, elderly individuals were found to be more prone to hematuria and thrombocytopenia. These results can improve the understanding of dengue in elderly individuals who live in or travel to tropical regions.

1 January 2023 in Cadernos de Saude Publica
Verified
Journal Article
Open access
KCKaren Cordovil
Karen Cordovil
WTWagner Tassinari
Wagner Tassinari
RORaquel A Oliveira
Raquel A Oliveira
YHYara Hökerberg
Yara Hökerberg
Contrary to international trends, the mortality rate of sickle cell disease increased in Brazil after the implementation of the neonatal screening program, probably due to improving access to diagnosis. This study aimed to assess differences in the temporal trend of the mortality rate and median age at death from sickle cell disease in Brazil, considering implemented measures to expand diagnosis, and improve health care access in-country and in the international scenario. Time series were extracted from the Brazilian Mortality Information System from 1996 to 2019. Changes in the mortality rate and median age at death were verified via segmented regression models, which were stratified by sex, region of residence, and age. Most deaths occurred in non-white people, young adults, and the Southeast and Northeast population. Sickle cell disease mortality rate increased until 2010 (13.31%; 95%CI: 6.37; 20.70), particularly in individuals aged 30 years or more (12.78%; 95%CI: 2.98; 23.53) and in the Northeast (12.27%; 95%CI: 8.92; 15.72). Most deaths occurred in the second decade of life (3.01 deaths/million), with a 59% increase in the median age of death in Brazil, from 27.6 to 30.3 years, more pronounced in females and the North Region. The observed gain in the survival of sickle cell disease in Brazil is still much lower than in developed countries and presents regional disparities, probably due to the lack of access to health care and recent treatments, such as hydroxyurea, still restricted to hematological referral centers in Brazilian capitals.